Bone marrow-derived Mesenchymal Stromal Cells cryopreserved at passage P2

DRUG2 trials

Sponsors

Hopital Fondation Adolphe De Rothschild, Fundacion Para La Investigacion Biomedica Hospital Infantil Universitario Nino Jesus

Conditions

AdrenoleukodystrophyPatient with severe eye chemical burns

Phase 1

OPEN-LABEL, PHASE I CLINICAL TRIAL TO EVALUATE THE SAFETY AND PRELIMINARY CLINICAL RESPONSE TO THE USE OF ALLOGENEIC BONE MARROW MESENCHYMAL STEM CELLS IN CHILDREN AND ADOLESCENTS WITH X-LINKED ADRENOLEUKODYSTROPHY CEREBRAL FORM.

Not yet recruitingCTIS2026-526701-14-00

Fundacion Para La Investigacion Biomedica Hospital Infantil Universitario Nino JesusAdrenoleukodystrophy

Target: 5Updated: 2026-10-13

Phase 2

SYMBOL CLINICAL : Treatment of severe ocular chemical burns by subconjunctival injection of allogeneic mesenchymal stem cells: a multicentre, single-arm, open-label phase II trial

Not yet recruitingCTIS2023-509713-37-00

Hopital Fondation Adolphe De RothschildPatient with severe eye chemical burns

Target: 21Updated: 2025-12-09